The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava

Annals of Internal Medicine

Volumn 136, Issue 1, 2002, Pages 42-53

  Ernst, E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BILOBALIDE; ECHINACEA EXTRACT; FLAVONE DERIVATIVE; GINKGO BILOBA EXTRACT; GINKGOLIDE; GINSENG EXTRACT; GLYCOSIDE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; KAVA EXTRACT; LACTONE; MONOAMINE OXIDASE INHIBITOR; ORAL ANTIDIABETIC AGENT; PENTOXIFYLLINE; PLACEBO; SABAL EXTRACT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HERBAL MEDICINE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MENTAL DISEASE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SEROTONIN SYNDROME; TINNITUS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036139750     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-1-200201010-00010     Document Type: Article

References (76)

1. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
2. The BBC survey of complementary medicine use in the UK
3. Herbal market levels after five years of boom
4. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials
5. Garlic shows promise for improving some cardiovascular risk factors
6. Harmless herbs? A review of the recent literature
7. Advising patients who seek alternative medical therapies
8. Ginkgo biloba for cerebral insufficiency
9. Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age
10. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease
11. Mikrozirkulation und viskoelastizität des vollblutes unter ginkgo-biloba-extrakt
12. Interactions between synthetic and herbal medicinal products. Part 2: A systematic review of the indirect evidence
13. St John's wort for depression
14. Hypericum for depression. An update of the clinical evidence
15. St John's wort for depression: A systematic review
16. Acute heart transplant rejection due to Saint John's wort
17. The chemistry and pharmacology of Echinacea species
18. Pregnancy outcome following gestational exposure to echinacea: A prospective controlled study
19. Phytotherapy in the treatment of benign prostatic hyperplasia: An update
20. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses
21. Ginkgo biloba for dementia: A systematic review of double-blind placebo-controlled trials
22. Ginkgo biloba for tinnitus: A review
23. Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials
24. Gingko biloba extract EGb 761 and pentoxifylline in intermittent claudication. Secondary analysis of the clinical effectiveness
25. Behandlung der PAVK mit ginkgo-biloba-extrakt (GBE) oder pentoxifylline
26. Exercise for intermittent claudication
27. Possible interactions between synthetic and herbal medicinal products. Part 1: A systematic review of the indirect evidence
28. St. John's wort for depression: A meta-analysis of well-defined clinical trials
29. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary
30. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks
31. Safety of hypericum in patients with depression
32. Incidence and clinical relevance of the interactions and side effects of hypericum preparations
33. Second thoughts about safety of St John's wort
34. Mechanismen der interaktionen mit johanniskraut
35. Indinavir concentrations and St John's wort
36. Safety of St John's wort (Hypericum perforatum)
37. Effect of Ginseng extract on lipid and sugar metabolism. I. Metabolic correlation between liver and adipose tissue
38. The efficacy of ginseng. A systematic review of randomised clinical trials
39. Evaluation of the ergogenic properties of ginseng
40. Non-organ specific cancer prevention of ginseng: A prospective study in Korea
41. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus
42. Probable interaction between warfarin and ginseng
43. Echinacea species as potential immunostimulatory drugs
44. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea
45. Echinacea for preventing and treating the common cold
46. Echinacea-associated anaphylaxis
47. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients
48. Serenoa repens for benign prostatic hyperplasia
49. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia
50. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain
51. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
52. D,L-kavain in comparison with oxazepam in anxiety disorders. A double-blind study of clinical effectiveness
53. Therapeutische möglichkeiten mit kava-Kava bei angsterkrankungen
54. Ergebnisse einer anwendungsbeobachtung L1090 mit laitan kapseln
55. Leberschädigungen unter kava-extrakten
56. Coma from the health food store: Interaction between kava and alprazolam
57. Kava dermopathy
58. Sebotropic drug reaction resulting from kava-kava extract therapy: A new entity?
59. Phytotherapeutic research
60. A guide to clinically tested herbal products on the US market
61. Who needs regulation or research?
62. Is integrative medicine the medicine of the future? A debate between Arnold S. Relman, MD, and Andrew Weil, MD
63. Traditional remedies and the "test of time"
64. Taking the edge off: Why patients choose St. John's Wort
65. UK and German media differ over complementary medicine
66. Risks associated with complementary therapies
67. Lay books on complementary/alternative medicine: A risk factor for good health?
68. Medicinal herbs in the United States: Research needs